September 7, 2018
SAN FRANCISCO, CA – Montreux Equity Partners is pleased to announce the launch of its new healthcare growth capital fund, Montreux Growth Partners II, L.P. The firm has completed its initial two investments out of the fund: Crown Laboratories, Inc., a specialty pharmaceutical company, and TigerConnect, Inc., a healthcare technology company. Montreux Growth Partners II will build on the success of its prior growth capital fund, which invested in a portfolio of high growth, commercial stage companies in clinical health, consumer wellness, and technology-enabled healthcare. Investments in this prior fund include MINDBODY (Nasdaq: MB), Kareo, Colorescience, Pure Life Renal, and KNOW Foods.
As its first investment in Montreux Growth Partners II, Montreux led a growth capital financing in Crown Laboratories, a leading, fully integrated, specialty pharmaceutical company focused on dermatology. Crown has a strong portfolio of consumer brands, including Blue Lizard and Vita Liberata, and a diverse portfolio of branded and generic dermatological pharmaceutical products. With this financing, Crown will continue to broaden its distribution across consumer OTC and prescription Rx channels and add new product lines to support its growth as a leading player focused on dermatology. The investment in Crown leverages Montreux’s extensive experience investing in companies addressing the attractive dermatology and aesthetic markets, including SkinMedica (acquired by Allergan for up to $375M), Colorescience, and GC Aesthetics.
In addition, Montreux led a new growth capital financing in TigerConnect, a healthcare technology company with a leading clinical communication and collaboration platform for hospitals and healthcare systems. TigerConnect’s recently launched TigerFlow enterprise solution provides real-time clinical collaboration tools that are integrated with existing hospital systems, such as their electronic health record (EHR) platforms, to significantly improve clinical workflow and improve provider productivity and patient satisfaction. As a leader in healthcare communication solutions, TigerConnect currently has an existing customer base of over 4,500 active organizations and had over 400 million texts sent across its platform in 2017. With the investment in TigerConnect, Montreux continues to build on its experience investing in leading SaaS-based healthcare technology companies, such as MINDBODY and Kareo.
About Montreux Equity Partners
Montreux Equity Partners is dedicated to making growth capital investments in high growth, category-leading companies with products, technologies, and services that are advancing health. Founded in 1993, Montreux has invested in more than 60 companies, including MINDBODY (Nasdaq: MB), Glaukos (NYSE: GKOS), Tobira Therapeutics (acquired by Allergan), MAKO Surgical (acquired by Stryker), SkinMedica (acquired by Allergan), and Renal CarePartners (acquired by Ambulatory Services of America). Montreux is based in San Francisco, CA, and is currently investing out of its second healthcare growth capital fund, Montreux Growth Partners II, L.P. For more information about Montreux Equity Partners, visit www.mepvc.com.
About Crown Laboratories, Inc.
Crown Laboratories, Inc. is a privately held, fully integrated, specialty pharmaceutical company, focused in dermatology, and committed to developing and providing a diverse portfolio of pharmaceutical and consumer products, which improve the quality of life for its customers. Crown Laboratories is an innovative company, whose Blue Lizard Australian Sunscreen and robust portfolio of dermatological products have paved the way for Crown Laboratories’ rapid growth. Crown Laboratories’ prescription portfolio includes key branded products AlaScalp, AlaQuin, Daxbia and Dermasorb HC & TA Kits. For more information about Crown Laboratories or its products, visit www.crownlaboratories.com.
About TigerConnect, Inc.
As healthcare’s largest provider of clinical communication solutions, TigerConnect helps physicians, nurses, and other staff communicate and collaborate more effectively, accelerating productivity, reducing costs, and improving patient outcomes. Trusted by more than 4,000 healthcare organizations, TigerConnect maintains 99.99% uptime and processes over 10 million messages each day. Its category-leading product innovations and advanced integrations with critical hospital systems deliver high value for hospitals and large health systems. For more information about TigerConnect, visit www.tigerconnect.com.